← Back to Search

Virus Therapy

Universal Anti-Viral Vaccine for Healthy Elderly Adults (ALLOPRIME Trial)

Phase 1 & 2
Waitlist Available
Research Sponsored by Mirror Biologics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 0 to day 28
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a special vaccine made from healthy blood cells to help elderly adults fight off any virus. The vaccine boosts the immune system by creating memory cells that quickly recognize and combat viruses.

Eligible Conditions
  • Coronavirus Disease (COVID-19)
  • Central Nervous System Viral Infection
  • Flu-Related Pain
  • Flu
  • Respiratory Syncytial Virus Pneumonia
  • Viral Diseases
  • Acute respiratory distress syndrome
  • Pneumonia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 0 to day 28
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 0 to day 28 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Proportion of subjects able to suppress viral propagation
Proportion of subjects with positive T-cell response
frequency of vaccine events

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: VaccinationExperimental Treatment1 Intervention
ID injection AlloStim Days 0, 3/4, 7, 10/11 and 14
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
AlloStim
2016
Completed Phase 2
~90

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Mirror Biologics, Inc.Lead Sponsor
14 Previous Clinical Trials
321 Total Patients Enrolled
Immunovative Therapies, Ltd.Lead Sponsor
13 Previous Clinical Trials
271 Total Patients Enrolled
David Fineberg, MDStudy DirectorMirror Biologics, Inc.
2 Previous Clinical Trials
~9 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top